BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36501006)

  • 1. Ketogenic Diets in the Management of Lennox-Gastaut Syndrome-Review of Literature.
    Skrobas U; Duda P; Bryliński Ł; Drożak P; Pelczar M; Rejdak K
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketogenic diet in patients with Lennox-Gastaut syndrome.
    Caraballo RH; Fortini S; Fresler S; Armeno M; Ariela A; Cresta A; Mestre G; Escobal N
    Seizure; 2014 Oct; 23(9):751-5. PubMed ID: 25011392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the modified Atkins diet in Lennox Gastaut syndrome.
    Sharma S; Jain P; Gulati S; Sankhyan N; Agarwala A
    J Child Neurol; 2015 Apr; 30(5):576-9. PubMed ID: 24659735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic diets for drug-resistant epilepsy.
    Martin-McGill KJ; Bresnahan R; Levy RG; Cooper PN
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD001903. PubMed ID: 32588435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy-A Review.
    Wells J; Swaminathan A; Paseka J; Hanson C
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32560503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome.
    Zhang Y; Wang Y; Zhou Y; Zhang L; Yu L; Zhou S
    Epilepsy Res; 2016 Dec; 128():176-180. PubMed ID: 27846468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
    Samanta D
    Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of corpus callosotomy and ketogenic diet in children with Lennox Gastaut syndrome: a systematic review and meta-analysis.
    Sharawat IK; Panda PK; Sihag RK; Panda P; Dawman L
    Childs Nerv Syst; 2021 Aug; 37(8):2557-2566. PubMed ID: 33871716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lennox-Gastaut syndrome. Management update.
    Al-Banji MH; Zahr DK; Jan MM
    Neurosciences (Riyadh); 2015 Jul; 20(3):207-12. PubMed ID: 26166587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
    Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
    Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome.
    Grosso S; Coppola G; Cusmai R; Parisi P; Spalice A; Foligno S; Verrotti A; Balestri P
    Acta Neurol Scand; 2014 Jun; 129(6):420-4. PubMed ID: 24479878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome.
    Kessler SK; McCarthy A; Cnaan A; Dlugos DJ
    Epilepsy Res; 2015 May; 112():18-26. PubMed ID: 25847334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
    Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
    Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lennox-Gastaut syndrome: a comprehensive review.
    Asadi-Pooya AA
    Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature.
    Lemmon ME; Terao NN; Ng YT; Reisig W; Rubenstein JE; Kossoff EH
    Dev Med Child Neurol; 2012 May; 54(5):464-8. PubMed ID: 22443637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.
    Lo SH; Lloyd A; Marshall J; Vyas K
    Clin Ther; 2021 Nov; 43(11):1861-1876.e16. PubMed ID: 34774333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Villanueva V; Carreño-Martínez M; Gil Nagel-Rein A; López-González FJ
    Rev Neurol; 2021 Apr; 72(S01):S1-S10. PubMed ID: 33908026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.